ConvaTec Group PLC Director/PDMR Shareholding (9818G)
30 Noviembre 2020 - 9:45AM
UK Regulatory
TIDMCTEC
RNS Number : 9818G
ConvaTec Group PLC
30 November 2020
30 November 2020
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a
Person Discharging Managerial Responsibility ("PDMR") in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
The Company has been informed that Shares held by Mr Karim
Bitar, Chief Executive Officer and a PDMR, were transferred into
nominee accounts for nil consideration. The transfer of Shares into
each nominee account completed as follows:
1. 616,234 Shares on 25 November 2020
2. 989,830 Shares on 26 November 2020
No change to the number of Shares beneficially held by Mr Bitar
has occurred in connection with the transfer of Shares and Mr Bitar
remains interested in the 1,606,064 Shares.
The attached notification, made in accordance with the
requirements of the EU Market Abuse Regulation, gives further
detail.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Karim Bitar
2 Reason for the notification
a) Position/Status Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary shares of 10p each in ConvaTec
financial instrument, Group Plc ("Shares")
type of instrument GB00BD3VFW73
Identification code
b) Nature of the transaction Transfer of 616,234 S hares to a nominee
account.
c) Price(s) and volume(s) Price(s) Volume(s)
N/A 616,234
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 25 November 2020
f) Place of the transaction Outside of a trading venue
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Karim Bitar
2 Reason for the notification
a) Position/Status Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the Ordinary shares of 10p each in ConvaTec
financial instrument, Group Plc ("Shares")
type of instrument GB00BD3VFW73
Identification code
b) Nature of the transaction Transfer of 989,830 Shares to a nominee
account
c) Price(s) and volume(s) Price(s) Volume(s)
N/A 989,830
d) Aggregated information
- Aggregated volume N/A
- Price N/A
e) Date of the transaction 26 November 2020
f) Place of the transaction Outside of a trading venue
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations &
Corporate Communications, ConvaTec, +44 (0)7826 447807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. Our vision, which
encompasses our purpose, is: Pioneering trusted medical solutions
to improve the lives we touch. Our products provide a range of
clinical and economic benefits including infection prevention,
protection of at-risk skin, improved patient outcomes and reduced
total cost of care. To learn more about ConvaTec, please visit
www.convatecgroup.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFFELTLIVII
(END) Dow Jones Newswires
November 30, 2020 10:45 ET (15:45 GMT)
Convatec (LSE:CTEC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Convatec (LSE:CTEC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
